Improvement in Infection Prevention and Control Performance Following Operational Research in Sierra Leone: A Before (2021) and After (2023) Study.
IPCAF
IPCAT
SORT IT
WASH
antimicrobial resistance
core components
health care-associated infections
operational research
quality of care
universal health coverage
Journal
Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042
Informations de publication
Date de publication:
23 Jul 2023
23 Jul 2023
Historique:
received:
28
06
2023
revised:
19
07
2023
accepted:
21
07
2023
medline:
28
7
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Infection prevention and control (IPC) is crucial to limit health care-associated infections and antimicrobial resistance. An operational research study conducted in Sierra Leone in 2021 reported sub-optimal IPC performance and provided actionable recommendations for improvement. This was a before-and-after study involving the national IPC unit and all twelve district-level secondary public hospitals. IPC performance in 2021 (before) and in 2023 (after) was assessed using standardized World Health Organization checklists. IPC performance was graded as: inadequate (0-25%), basic (25.1-50%), intermediate (50.1-75%), and advanced (75.1-100%). The overall IPC performance in the national IPC unit moved from intermediate (58%) to advanced (78%), with improvements in all six core components. Four out of six components achieved advanced levels when compared to the 2021 levels. The median score for hospitals moved from basic (50%) to intermediate (59%), with improvements in six of eight components. Three of four gaps identified in 2021 at the national IPC unit and four of seven at hospitals had been addressed by 2023. The study highlights the role of operational research in informing actions that improved IPC performance. There is a need to embed operational research as part of the routine monitoring of IPC programs.
Identifiants
pubmed: 37505672
pii: tropicalmed8070376
doi: 10.3390/tropicalmed8070376
pmc: PMC10383112
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Références
Trop Med Infect Dis. 2021 May 31;6(2):
pubmed: 34072803
Infect Control Hosp Epidemiol. 2005 Nov;26(11):891-4
pubmed: 16320985
Lancet Infect Dis. 2009 Nov;9(11):711-7
pubmed: 19850229
Int J Environ Res Public Health. 2021 May 25;18(11):
pubmed: 34070423
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
Healthcare (Basel). 2022 Oct 28;10(11):
pubmed: 36360488
Infect Drug Resist. 2023 Apr 04;16:1997-2006
pubmed: 37038477
Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1173-7
pubmed: 20533071
Trop Med Infect Dis. 2021 May 01;6(2):
pubmed: 34062871
Int J Environ Res Public Health. 2022 May 06;19(9):
pubmed: 35565037
J Hosp Infect. 2021 Feb;108:94-103
pubmed: 33271215
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Lancet Glob Health. 2020 Jun;8(6):e780-e789
pubmed: 32389195
Trop Med Int Health. 2013 Aug;18(8):1025-8
pubmed: 23718688
Trop Med Infect Dis. 2019 Mar 15;4(1):
pubmed: 30875884
Lancet Glob Health. 2019 Jun;7(6):e698-e700
pubmed: 31060971
Antimicrob Resist Infect Control. 2022 Oct 6;11(1):125
pubmed: 36203207
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Int J Environ Res Public Health. 2022 Apr 11;19(8):
pubmed: 35457449
Am J Infect Control. 2014 Jun;42(6):643-8
pubmed: 24837115
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Trop Med Int Health. 2012 Nov;17(11):1409-11
pubmed: 22897763
Indian J Tuberc. 2020 Dec;67(4S):S23-S32
pubmed: 33308668
Lancet Infect Dis. 2022 Jun;22(6):845-856
pubmed: 35202599
Public Health Action. 2017 Jun 21;7(Suppl 1):S94-S99
pubmed: 28744446
Health Secur. 2018 Fall;16(S1):S54-S65
pubmed: 30480501
Infect Control Hosp Epidemiol. 2010 Jan;31(1):12-20
pubmed: 19925270